Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 1 TO FORM S-1 - NEUROONE MEDICAL TECHNOLOGIES Corp | ea125947-s1a_neuroonemedical.htm |
| EX-5.1 - OPINION OF HONIGMAN LLP - NEUROONE MEDICAL TECHNOLOGIES Corp | ea125947ex5-1_neuroonemed.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
NeuroOne Medical Technologies Corporation
Eden Prairie, Minnesota
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated December 20, 2019, relating to the consolidated financial statements of NeuroOne Medical Technologies Corporation appearing in the Company’s Annual Report on Form 10-K for the year ended September 30, 2019. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP
Minneapolis, Minnesota
August 26, 2020